Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2019 |
Accounting Policies [Abstract] |
|
Schedule of fair value on a nonrecurring basis |
|
|
Quoted
Price in Active Markets for Identical Assets
(Level 1) |
|
|
Significant
Other Observable Inputs
(Level 2) |
|
|
Significant
Unobservable Inputs (Level 3) |
|
|
Balance
at June 30, 2019 |
|
|
Impairment
Loss |
|
Patents
and other technologies |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,091,903 |
|
|
$ |
1,091,903 |
|
|
$ |
- |
|
|
|
Quoted
Price in Active Markets for Identical Assets
(Level 1) |
|
|
Significant
Other Observable Inputs
(Level 2) |
|
|
Significant
Unobservable Inputs (Level 3) |
|
|
Balance
at December 31, 2018 |
|
|
Impairment
Loss |
|
Patents
and other technologies |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
1,255,689 |
|
|
$ |
1,255,689 |
|
|
$ |
- |
|
|
Schedule of cash balances by geographic area |
Country: |
|
June
30, 2019 |
|
|
December
31, 2018 |
|
United States |
|
$ |
2,761,051 |
|
|
|
81.2 |
% |
|
$ |
1,035,802 |
|
|
|
46.0 |
% |
China |
|
|
640,253 |
|
|
|
18.8 |
% |
|
|
1,216,485 |
|
|
|
54.0 |
% |
Total cash |
|
$ |
3,401,304 |
|
|
|
100.0 |
% |
|
$ |
2,252,287 |
|
|
|
100.0 |
% |
|
Schedule of reconciliation of basic and diluted net loss per share |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June
30, |
|
|
June
30, |
|
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
Net
loss available to Avalon GloboCare Corp. common shareholders for basic and diluted net loss per share of common stock |
|
$ |
(4,357,224 |
) |
|
$ |
(1,294,394 |
) |
|
$ |
(8,763,040 |
) |
|
$ |
(2,775,973 |
) |
Weighted average
common stock outstanding - basic and diluted |
|
|
75,183,354 |
|
|
|
71,979,678 |
|
|
|
74,437,336 |
|
|
|
71,122,356 |
|
Net
loss per common share attributable to Avalon GloboCare Corp. common shareholders - basic and diluted |
|
$ |
(0.06 |
) |
|
$ |
(0.02 |
) |
|
$ |
(0.12 |
) |
|
$ |
(0.04 |
) |
|
Schedule of the effect of including these potential shares was antidilutive |
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
Stock options |
|
|
5,070,000 |
|
|
|
2,610,000 |
|
|
|
5,070,000 |
|
|
|
2,610,000 |
|
Warrants |
|
|
1,714,288 |
|
|
|
578,891 |
|
|
|
1,714,288 |
|
|
|
578,891 |
|
Potentially dilutive securities |
|
|
6,784,288 |
|
|
|
3,188,891 |
|
|
|
6,784,288 |
|
|
|
3,188,891 |
|
|